Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Pemetrexed combinations found highly effective against NSCLC cells

March 13, 2007

Array BioPharma reports on anticancer activity of its p38 MAPK inhibitor

March 13, 2007

Biomarker studies test AZD-0530's potential in managing bone metastasis

March 13, 2007

Positive data reported from phase Ib study of TASQ

March 13, 2007

Natural toxin shows potential against prostate cancer in vitro

March 13, 2007

Claudins validated as targets in ovarian cancer

March 12, 2007

N-69: a novel nucleoside analogue potentially useful in melanoma therapy

March 12, 2007

Azixa begins phase II for glioblastoma multiforme

March 12, 2007

AS-1404 with carboplatin and paclitaxel shows good response rate in NSCLC

March 9, 2007

New phase I/II trial studies Ferritarg P for Hodgkin's disease

March 9, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...